AIM Vaccine Co., Ltd. (HKG:6660)
Hong Kong · Delayed Price · Currency is HKD 1.615
+0.030 (1.89%)
Sep 18, 2026, 4:08 PM HKT
AIM Vaccine Market Cap
AIM Vaccine has a market cap or net worth of 1.98 billion as of September 18, 2026. Its market cap has decreased by -65.64% in one year.
Market Cap
1.98B
Enterprise Value
3.74B
Revenue
1.30B
Ranking
n/a
PE Ratio
n/a
Stock Price
1.62
ChartMarket Cap Chart
Since October 6, 2022, AIM Vaccine's market cap has decreased from 20.15B to 1.98B, a decrease of -90.17%. That is a compound annual growth rate of -44.39%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 18, 2026 | 1.98B | -49.69% |
| Dec 31, 2025 | 3.94B | -47.05% |
| Dec 31, 2024 | 7.44B | -21.78% |
| Dec 29, 2023 | 9.51B | -67.02% |
| Dec 30, 2022 | 28.82B | 43.02% |
| Oct 6, 2022 | 20.15B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Beijing Luzhu Biotechnology | 2.76B |
| Clover Biopharmaceuticals | 2.75B |
| PegBio | 2.27B |
| Antengene Corporation | 2.25B |
| Frontage Holdings | 2.10B |
| HighTide Therapeutics | 1.89B |
| Guangzhou Innogen Pharmaceutical Group | 1.76B |
| Mabpharm | 1.61B |